Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Suzhou's CStone Pharma Schedules $304 Million Hong Kong IPO for Next Week

Junshi Biopharma Rises 22% Following $394 Million Hong Kong IPO

Hong Kong's Aptorum Stages $12 Million US IPO for Drug Development

WuXi AppTec Completes Hong Kong IPO; Finishes First Trading Session Unchanged

Shanghai Junshi Bioscience to Raise $414 Million in Hong Kong IPO

Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Shanghai , China
March 5-6, 2019

Shanghai , China
March 26-28, 2019